Brooks Laboratories Limited — Board Meeting, 13-08-2025: Outcome of Board Meeting

Brooks Laboratories' board has approved its consolidated financial results for the quarter ended June 30, 2025. The company delivered solid performance with Revenue from Operations reaching ₹25.51 Cr. Net Profit after tax stood impressively at ₹9.58 Cr. A key driver for this profit was the ₹6.93 Cr share from its jointly controlled entity, Brooks Steriscience Limited, highlighting its significant contribution. Consolidated Earnings Per Share (EPS) for the quarter is ₹3.25.